Eosinophilic vasculitis of aortic valve in EGPA: a life-threatening onset of disease.

J AsthmaMay 21, 2026 (epub)

Niccolò Paoletti, Leandro Cosco, Emanuele Vivarelli et al.

✦ AI-curated · Sources linked

Case in brief

A 51-year-old man with eosinophilic severe asthma and chronic rhinosinusitis presented with worsening dyspnea and cardiac arrest after two months of low-grade fever and malaise. He underwent surgery for acute torrential aortic regurgitation, revealing eosinophilic vasculitis of the aortic valve. Despite low blood eosinophils due to mepolizumab therapy, he was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA) and discharged with full recovery after treatment.

What made this case unusual

This case highlights a rare presentation of eosinophilic vasculitis affecting the aortic valve, which is not commonly reported in EGPA.

Diagnostic / clinical pearl

Clinicians should consider EGPA in patients with severe asthma and cardiac symptoms, even when eosinophil levels are low due to ongoing therapy.

Why it matters

This case underscores the need for careful monitoring and potential adjustment of mepolizumab dosage in patients with severe EGPA to prevent life-threatening complications.

Source

Published in J Asthma. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Allergy & Immunology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.